Related Experiment Video
Updated: Mar 24, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Emerging Treatments in Schizophrenia: Highlights from Recent Supplementation and Prevention Trials
Hannah E Brown1, Joshua L Roffman
1From Harvard Medical School and Department of Psychiatry, Massachusetts General Hospital, Boston (Dr. Brown) and Charlestown (Dr. Roffman), MA.
Abstract:
In this column we examine the recent literature regarding adjunctive antipsychotic treatment of schizophrenia. We provide a brief introduction outlining the urgent need for new therapeutics, particularly for the treatment of negative and cognitive symptoms of schizophrenia. We then address (by mechanism of action) the most extensively studied adjunctive antipsychotic treatments. We conclude that adjunctive treatments targeting glutamatergic modulation, as well as supplementation with certain vitamins, have the strongest evidence for use in the treatment of schizophrenia. Further, larger randomized, controlled trials are needed, focusing on certain subgroups of patients and specific antipsychotic medications.
More Related Videos
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Psychosis and Antipsychotic Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Psychological and Sociocultural Causes of Schizophrenia

